|

|

|
|

|
ANTIBODIES TO KINESINS
The kinesins (KIFs) make up a
large superfamily of motor proteins that function in intracellular
transport along microtubules. Kinesin activity has been linked to various
cellular functions such as organelle and vesicle transport, mitotic spindle
formation, chromosome segregation, and cytokinesis. Structurally, all
kinesins contain a motor domain with microtubule and nucleotide binding
sites that utilize ATP to target cargo along microtubule filaments. The
kinesin motor proteins have been implicated in human disease.A mutation in
the KIF1B locus is associated with Charcot-Marie-Tooth disease (CMT2A)
which is characterized by a progressive dysfunction of peripheral neurons
and a lack of synaptic vesicle transport in nerve endings and axons. Over
forty members of the KIF family have been identified and well
characterized. However, when one considers the multitude of cellular tasks
involving the intracellular transport of cargo, many questions concerning
KIF regulation remain unanswered.
Please follow the links in the table for specific product information our
our current selection of antibodies to KIF family members.
|

|

Detection of Human KIF1C/LTXS1 by
WB and IP. Samples:
Whole cell lysate (5, 15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded)
from HeLa cells. Antibodies:
Affinity purified rabbit anti-KIF1C/LTXS1
antibody A301-070A used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used
for IP at 3 mcg/mg lysate. KIF1C/LTXS1 was also immunoprecipitated by
rabbit anti-KIF1C/LTXS1
antibodies A301-069A, A301-071A and A301-072A, which recognize other
epitopes. For blotting immunoprecipitated KIF1C/LTXS1,
ReliaBLOT® Reagents and Procedures (Cat. No. WB120)
were used. Detection:
Chemiluminescence with exposure times of 30 seconds (A) and 10 seconds (B).
|
|

|
NEW POLYCLONAL ANTIBODIES
|
CAF-1
p60
|
Applications: WB, IP
|
|
CHD4/Mi2
beta
|
Applications: WB, IP
|
|
CPSF73
|
Applications: WB, IP
|
|
CSTF64
|
Applications: WB, IP
|
|
CSTF77
|
Applications: WB, IP
|
|
DDX51
|
Applications: WB, IP
|
|
EG5/KIF11
|
Applications: WB, IP
|
|
HMG20B/BRAF35
|
Applications: WB, IP
|
|
KIF1C/LTXS1
|
Applications: WB, IP
|
|
KIF4A
|
Applications: WB, IP
|
|
KIF13A
|
Applications: WB, IP
|
|
KIF18A
|
Applications: WB, IP
|
|
NCOA62
|
Applications: WB, IP, IHC
|
|
NF2
isoform1
|
Applications: WB, IP, IHC
|
|
NIF1
|
Applications: WB, IP, IHC
|
|
NMI
|
Applications: WB, IP, IHC
|
|
NONO
|
Applications: WB, IP, IHC
|
|
p14ARF
|
Applications: WB, IHC
|
|
p73
|
Applications: WB, IP, IHC
|
|
PPP2R5D
|
Applications: WB, IP
|
|
RBM9
|
Applications: WB, IP, IHC
|
|
RecQ1
|
Applications: WB, IP, IHC
|
|
Senataxin
|
Applications: WB, IP
|
|
SMARCA1/SNF2L
|
Applications: IP
|
|
SMARCB1/SNF5
|
Applications: WB, IP
|
|
SMC6
|
Applications: WB, IP, IHC
|
|
XRN2
|
Applications: WB, IP
|
New Application
AbVantage
and ReliaBLOT are trademarks of Bethyl Laboratories, Inc.
READ MORE
|

|
A. Detection of Human KIF13A by WB and IP.
Samples: Whole cell lysate (5, 15 and 50 mcg for WB; 1 mg
for IP, 20% of IP loaded) from HeLa cells. Antibodies: Affinity purified
rabbit anti-KIF13A
antibody A301-077A used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used
for IP at 3 mcg/mg lysate. KIF13A
was also immunoprecipitated by rabbit anti-KIF13A
antibody A301-078A, which recognizes a downstream epitope. For blotting
immunoprecipitated KIF13A,
ReliaBLOT® Reagents and Procedures (Cat. No. WB120)
were used. Detection:
Chemiluminescence with exposure times of 30 seconds (A) and 10 seconds (B).

Detection of Human KIF4A by WB and
IP. Samples:
Whole cell lysate from HeLa (5, 15 and 50 mcg for WB; 1 mg for IP, 20% of
IP loaded) and 293T (T; 50 mcg) cells. Antibodies: Affinity purified
rabbit anti-KIF4A
antibody A301-074A used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used
for IP at 3 mcg/mg lysate. KIF4A
was also immunoprecipitated by rabbit anti-KIF4A
antibody A301-073A, which recognizes an upstream epitope. For blotting
immunoprecipitated KIF4A,
ReliaBLOT® Reagents and Procedures (Cat. No. WB120)
were used. Detection:
Chemiluminescence with exposure times of 30 seconds (A) and 10 seconds (B).
|
|

|
RECENT CITATIONS ...
A functional genomic screen
identifies a role for TAO1 kinase in spindle-checkpoint signalling.
Viji M. Draviam, Frank Stegmeier, Grzegorz Nalepa, Mathew E. Sowa, Jing
Chen, Anthony Liang, Gregory J. Hannon, Peter K. Sorger, J. Wade Harper,
Stephen J. Elledge
...rabbit
anti-BubR1 (kind gift from H. Yu, Southwestern Medical School, Dallas, TX),
rabbit anti-TAO1 (Bethyl Laboratories, Montgomery, TX) were used. For
immunoprecipitation reactions, cells were lysed in CHAPS lysis...
Nature Cell
Biology 9, 556 - 564 (01 May 2007).
The SMC5/6 complex maintains telomere length in ALT
cancer cells through SUMOylation of telomere-binding proteins.
Patrick Ryan Potts, Hongtao Yu
...anti-SCC1
(Bethyl Laboratories, A300-080A), anti-SMC1 (Bethyl Laboratories,
A300-055A), anti-SMC5 (Bethyl Laboratories, A300-236A), anti-SMC6 (Bethyl
Laboratories, A300-A237A) and anti-TRF2...
Nature
Structural & Molecular Biology 14, 581 - 590 (01 Jul 2007).
Regulation of ATR-dependent pathways by the FHA domain
containing protein SNIP1.
K C Roche, S Rocha, C P Bracken, N D Perkins
...and
anti-phospho-SMC1 serine 966 and anti-SMC1 antibodies; Bethyl
Laboratories, Montgomery, TX, USA)...
Oncogene
26, 4523 - 4530 (05 Jul 2007).
|

|

Detection of Human EG5/KIF11 by WB
and IP. Samples: Whole cell lysate from HeLa (5, 15 and
50 mcg for WB; 1 mg for IP, 20% of IP loaded) and 293T (T; 50 mcg) cells.
Antibodies: Affinity purified rabbit anti-EG5/KIF11
antibody A301-075A used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used
for IP at 3 mcg/mg lysate. EG5/KIF11
was also immunoprecipitated by rabbit anti-EG5/KIF11
antibody A301-076A, which recognizes a downstream epitope. For blotting
immunoprecipitated EG5/KIF11,
ReliaBLOT® Reagents and Procedures (Cat. No. WB120)
were used. Detection:
Chemiluminescence with exposure times of 30 seconds (A) and 10 seconds (B).
|
|

|

|